Cannabis firm Trulieve posts wider Q3 net loss

Overview

• Trulieve Q3 revenue rises 1% yr/yr to $288 mln, with 59% gross margin

• Company reports Q3 net loss of $27 mln, adjusted net loss of $12 mln

• Trulieve generated $77 mln in cash flow from operations in Q3

Result Drivers

• RETAIL SALES - 94% of Q3 revenue came from retail sales, contributing significantly to overall performance

• NEW PRODUCT LAUNCHES - Launched new Roll One Clutch All In One vapes in Florida, selling out in under two weeks

• LOYALTY PROGRAM - 77% of transactions in Q3 were from loyalty program members, enhancing customer retention

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the pharmaceuticals peer group is "buy"

• Wall Street's median 12-month price target for Trulieve Cannabis Corp is C$17.00, about 45.2% above its November 4 closing price of C$9.32

Press Release: ID:nCNWvMykJa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.